30.01.2020 • News

Lanxess Digitizes its Global Asset Base

Matthias Zachert, CEO of LANXESS and Sanjay Brahmawar, CEO of Software AG,...
Matthias Zachert, CEO of LANXESS and Sanjay Brahmawar, CEO of Software AG, discussed LANXESS’ digitalisation strategy

German specialty chemicals producer Lanxess is pressing ahead with the digitalization of production. In its latest move, the company said it has implemented a self-service analytics system for time-series data in many areas of its global plant fleet.

To date, the Cologne-based company has equipped nearly two thirds of its roughly 120 plants worldwide with the self-service analysis platform TrendMiner, including all major production sites in Germany, Belgium, the US and India. Only smaller plants with less complex processes have not yet been updated.

With the program, employees can autonomously analyze manufacturing processes and measurement data, while detecting patterns and trends that would indicate production irregularities.

The digital toolbox is also credited with improving capacity utilization as well as product quality while the same time performing predictive maintenance and making more efficient use of raw materials and energy use. Digitalization is also said to be a key driver in reducing operating costs.

In some cases, digital officer Jörg Hellwig said, cost saving has been in the six-digit euro range. He added that the company’s “digital transformation” helps its chemists and chemical engineers competence in the field of digital data analytics that will make them “fit for the future.”

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.